Elevate Uranium (ASX: EL8) Stock & Uranium Update

Aditi Sarkar

29 July 2026 11:32 PM AEST

Elevate Uranium (ASX: EL8) Stock & Uranium Update

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

Elevate Uranium (ASX: EL8) is trading close to its 12-month lows even as the uranium price holds above US$85 a pound.
In short, EL8 sits closer to its recent floor than its ceiling, with a market capitalisation around A$107–114 million.
No JORC ore reserve or completed feasibility study underpins the portfolio yet, placing EL8 firmly at the exploration-to-development end of the spectrum.
Trade press including Mining Weekly reported that Elevate lifted its interest in the Marenica project to about 90 per cent via two agreements around July 2026, and flagged resource growth there earlier in the year.

Elevate Uranium (ASX: EL8) is trading close to its 12-month lows even as the uranium price holds above US$85 a pound. We weigh its Namibian resources, U-pgrade technology, balance sheet and risks.

Company Overview

Formerly Marenica Energy, Elevate Uranium is a dual-listed explorer and developer (ASX and the Namibian Stock Exchange) built around a portfolio of uranium projects plus proprietary processing technology. Its Namibian ground is anchored by the Koppies and Marenica calcrete-style deposits, complemented by four wholly owned Australian projects — including the Angela deposit in the Northern Territory (a reported ~31 Mlb) and Thatcher Soak in Western Australia (~11 Mlb).

Recent Developments

Momentum in 2026 has centred on Namibia. Trade press including Mining Weekly reported that Elevate lifted its interest in the Marenica project to about 90 per cent via two agreements around July 2026, and flagged resource growth there earlier in the year. The company has also expanded through the acquisition of Uranium Generation Pty Ltd, completed in December 2025 for a reported A$4.9 million (A$2.5 million cash plus shares and a 1 per cent net smelter royalty). Continued drilling to…

Financial and Operational Snapshot

As an explorer with negligible revenue, EL8's balance sheet is the number that matters. Its FY2025 accounts (year to June 2025) showed cash equivalent to roughly A$0.06 per share; on a share count near 465 million, that implies cash in the high-A$20 million range. Simply Wall St estimates annual free cash outflow near A$9.3 million and notes the company carries essentially no debt. The exact figure from the most recent quarterly Appendix 5B could not be independently verified for this…

What May Be Watched Next

Watch for: resource upgrades at Koppies and Marenica; consolidation of Marenica ownership; any scoping or pre-feasibility study that attaches capital and operating numbers to U-pgrade; and confirmation of the cash position in the June 2026 quarterly. Corporate activity across Namibia's uranium district — home to established producers — could also draw attention to EL8's ground. All such milestones are forward-looking and unguaranteed.

Key Risks

The risks are those of any junior: no reserves or feasibility study, reliance on technology not yet proven at commercial scale, heavy single-jurisdiction concentration in Namibia, sovereign and permitting exposure, uranium-price sensitivity, and near-certain future dilution. The share price sitting near the bottom of its 12-month range reflects some of this caution.

What does Elevate Uranium (ASX do?

What is the latest development?

What financial or operational point stands out?

What may be watched next?

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.